MarketCapTrends
VYGR

Voyager Therapeutics Inc.

NASDAQ · Healthcare

Voyager Therapeutics Inc. annual/quarterly net income history and growth rate from 2015 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

  • Voyager Therapeutics Inc. net income for the quarter ending March 31, 2026 was -27.9 M, a 9.94% decrease year-over-year.
  • Voyager Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -120.2 M, a 113.12% increase year-over-year.
  • Voyager Therapeutics Inc. annual net income for 2025 was -119.7 M, a 84.18% increase from 2024.
  • Voyager Therapeutics Inc. annual net income for 2024 was -65.0 M, a 149.12% decrease from 2023.
  • Voyager Therapeutics Inc. annual net income for 2023 was 132.3 M, a 385.14% decrease from 2022.
  • Voyager Therapeutics Inc. annual net income for 2022 was -46.4 M.
Net Income
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %